Gossamer Bio Shareholders Are Encouraged to Contact Johnson Fistel for More Information About Potentially Recovering Their Losses

SAN DIEGO, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Gossamer Bio, Inc. (NASDAQ: GOSS). The investigation focuses on Gossamer’s executive officers and whether investor losses may be recovered under federal securities laws. What if I purchased Gossamer Bio securities? If you purchased Gossamer Bio securities and suffered losses on your investment, join our investigation now: Click here to join the investigation. Click here to join the i ...